Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes: A Meta-analysis of Randomized Controlled Trials

Briel, Matthias, Schwartz, Gregory G., Thompson, Peter L., de Lemos, James A., Blazing, Michael A., van Es, Gerrit-Anne, Kayikçioğlu, Meral, Arntz, Hans-Richard, den Hartog, Frank R., Veeger, Nic J. G. M., Colivicchi, Furio, Dupuis, Jocelyn, Okazaki, Shinya, Wright, R. Scott, Bucher, Heiner C., Nordmann, Alain J. · 2006 · JAMA

Abstract

CONTEXT: The short-term effects of early treatment with statins in patients after the onset of acute coronary syndromes (ACS) for the outcomes of death, myocardial infarction (MI), and stroke are unclear. OBJECTIVE: To evaluate relevant outcomes of patients from randomized controlled trials comparing early statin therapy with placebo or usual care at 1 and 4 months following ACS. DATA SOURCES AND STUDY SELECTION: Systematic search of electronic databases (MEDLINE, EMBASE, PASCAL, Cochrane Central Register) from their inception to August 2005, which was supplemented by contact with experts in the field. Two reviewers independently determined the eligibility of randomized controlled trials that compared treatment with statins with a control, were initiated within 14 days after onset of ACS, and had a minimal follow-up of 30 days. Trials with cerivastatin were only included in a sensitivity analysis. DATA EXTRACTION: Information on baseline characteristics of included trials and patients, reported methodological quality, lipid levels, and clinical outcome was independently extracted by 2 investigators. Investigators from each included trial contributed additional data if necessary. DATA SYNTHESIS: Twelve trials involving 13 024 patients with ACS were included in the meta-analysis. The risk ratios for the combined end point of death, MI, and stroke for patients treated with early statin therapy compared with control therapy were 0.93 (95% confidence interval [CI], 0.80-1.09; P = .39) at 1 month and 0.93 (95% CI, 0.81-1.07; P = .30) at 4 months following ACS. There were no statistically significant risk reductions from statins for total death, total MI, total stroke, cardiovascular death, fatal or nonfatal MI, or revascularization procedures (percutaneous coronary intervention or coronary artery bypass graft surgery). Sensitivity analyses with restriction to trials of high quality or with additional data from a large trial using cerivastatin indicated summary risk ratios even closer to 1. CONCLUSION: Based on available evidence, initiation of statin therapy within 14 days following onset of ACS does not reduce death, MI, or stroke up to 4 months.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.295.17.2046

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 170

Metadata

Authors
Briel, M., Schwartz, G. G., Thompson, P. L., de Lemos, J. A., Blazing, M. A., van Es, G.-A., Kayikçioğlu, M., Arntz, H.-R., den Hartog, F. R., Veeger, N. J. G. M., Colivicchi, F., Dupuis, J., Okazaki, S., Wright, R. S., Bucher, H. C., & Nordmann, A. J.
Venue
JAMA
Published
2006-05-03
Volume
295
Issue
17
Pages
2046
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2132610854
Cited by
170
References
11
FWCI
19.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes: A Meta-analysis of Randomized Controlled Trials. https://app.cochat.ai/papers/10.1001/jama.295.17.2046
The paper
Briel, M., Schwartz, G. G., Thompson, P. L., de Lemos, J. A., Blazing, M. A., van Es, G.-A., Kayikçioğlu, M., Arntz, H.-R., den Hartog, F. R., Veeger, N. J. G. M., Colivicchi, F., Dupuis, J., Okazaki, S., Wright, R. S., Bucher, H. C., & Nordmann, A. J. (2006). Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes: A Meta-analysis of Randomized Controlled Trials. JAMA. https://doi.org/10.1001/jama.295.17.2046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.